Concepedia

Emilio Cosimo

EC

Statistics

Publications

12

Citations

600

H-Index

11

Active since

2001

Affiliations

University of Glasgow(Current)

Gartnavel General Hospital

Royal Alexandra Hospital

Cancer Research UK Scotland Institute

University of Ulster

Emilio Cosimo is an author at University of Glasgow specializing in oncology, molecular oncology, and pharmacology.

ORCID

Publications per year

2001–2023

12

Publications

12

Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro‐survival microenvironmental signals

Alison M. McCaig, Emilio Cosimo, Michael T. Leach et al. · British Journal of Haematology · 2011 · 81 citations · Full text

, , +17

Complement deficiencies limit CD20 monoclonal antibody treatment efficacy in CLL

Odette Middleton, Emilio Cosimo, Edwina Dobbin et al. · Leukemia · 2014 · 78 citations

, , +14

Loss of Reelin Expression in Breast Cancer Is Epigenetically Controlled and Associated with Poor Prognosis

Torsten Stein, Emilio Cosimo, Xinzi Yu et al. · American Journal Of Pathology · 2010 · 77 citations · Full text

, , +15

Inhibition of neuroblastoma-induced angiogenesis by fenretinide

Doménico Ribatti, Giulio Alessandri, Manuela Baronio et al. · International Journal of Cancer · 2001 · 74 citations · Full text

, , +12

[131I]<i>meta</i>-Iodobenzylguanidine and Topotecan Combination Treatment of Tumors Expressing the Noradrenaline Transporter

A. McCluskey, Marie Boyd, Susan C. Ross et al. · Clinical Cancer Research · 2005 · 65 citations · Full text

, , +13

1–5 of 12